Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Sort descending Expiration Date Program Official
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer PAR-22-061 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/08/2025 Young Kim, Ph.D.
Basic Research in Cancer Health Disparities PAR-21-323 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-324 (R03 Clinical Trial Not Allowed) R03 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-322 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-280 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/08/2027 Edward Sauter, M.D., Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/15/2026 Sudhir Srivastava, Ph.D., M.P.H.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices RFA-EB-22-002 (R18 Clinical Trial Not Allowed) R18 Clinical Trial Not Allowed 06/18/2025 Rachel Altshuler, Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) R00, K99 Clinical Trial Not Allowed 10/15/2026 Jessica Faupel-Badger, Ph.D., M.P.H.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-21-330 (U01 Clinical Trial Not Allowed) U01 Clinical Trial Not Allowed 10/12/2024 Claire Zhu, Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-009 (R33 Clinical Trial Not Allowed) R33 Clinical Trial Not Allowed 10/02/2024 Guillermo Marquez, Ph.D.